10.20USD+5.97%Mkt Cap: 84.37M USDP/E: —Last update: 2026-06-01
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally.…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap84.37M USD
Enterprise Value81.62M USD
Revenue (TTM)34.90M USD
Gross Profit27.79M USD
Net Income (TTM)-13.97M USD
Revenue/Share4.035 USD
Last Price10.20 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees83
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-17.75
PEG—
EV/EBITDA-5.72
EV/Revenue2.34
P/S2.32
P/B-13.94
EPS (TTM)-1.77
EPS (Forward)-0.55
52W Range
4.16099% of range10.27
52W High10.27 USD
52W Low4.160 USD
Profitability
Gross Margin86.75%
Oper. Margin-55.47%
EBITDA Margin-40.92%
Profit Margin-43.60%
ROE817.20%
ROA-74.82%
Growth
Revenue Growth42.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.19M USD
CapEx (TTM)66.00K USD
FCF Margin-2.49%
FCF Yield-1.03%
Net Debt655.00K USD
Net Debt/EBITDA-0.05
Balance Sheet
Debt/Equity-5.50
Current Ratio1.02
Quick Ratio0.79
Book Value/Sh-0.7000 USD
Cash/Share1.064 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateFeb 15, 2023
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)19.17 USD
Target Range12.00 USD – 26.00 USD
# Analysts5
Ownership
Shares Out.8.30M
Float5.26M
Insiders37.27%
Institutions9.18%
Short Interest
Short Ratio5.1d
Short % Float3.69%
Short % Out.3.49%
Shares Short289.67K
Short (prev mo.)341.29K
Technical
SMA 506.538 (+56.1%)
SMA 2005.771 (+76.8%)
Beta0.68
S&P 52W Chg27.94%
Avg Vol (30d)97.58K
Avg Vol (10d)173.18K
Technical Indicators
RSI (14)76.4
MACD0.6268
MACD Signal0.2432
MACD Hist.+0.3836
BB Upper9.351 USD
BB Middle6.967 USD
BB Lower4.583 USD
BB Width68.44%
ATR (14)0.7369 USD
Vol Ratio (20d)2.89x